Copyright Reports & Markets. All rights reserved.

Global Targeted Metabolomics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Targeted Metabolomics by Method
    • 1.3.1 Overview: Global Targeted Metabolomics Market Size by Method: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Targeted Metabolomics Consumption Value Market Share by Method in 2025
    • 1.3.3 NMR
    • 1.3.4 GC-MS
    • 1.3.5 LC-MS
    • 1.3.6 HPLC-MS
  • 1.4 Classification of Targeted Metabolomics by Service Type
    • 1.4.1 Overview: Global Targeted Metabolomics Market Size by Service Type: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Targeted Metabolomics Consumption Value Market Share by Service Type in 2025
    • 1.4.3 Standardized Quantitative Services
    • 1.4.4 Customized Service
  • 1.5 Global Targeted Metabolomics Market by Application
    • 1.5.1 Overview: Global Targeted Metabolomics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Academic and Research Institutions
    • 1.5.3 Pharmaceutical and Biotechnology Companies
    • 1.5.4 Contract Research Organizations
  • 1.6 Global Targeted Metabolomics Market Size & Forecast
  • 1.7 Global Targeted Metabolomics Market Size and Forecast by Region
    • 1.7.1 Global Targeted Metabolomics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.7.2 Global Targeted Metabolomics Market Size by Region, (2021-2032)
    • 1.7.3 North America Targeted Metabolomics Market Size and Prospect (2021-2032)
    • 1.7.4 Europe Targeted Metabolomics Market Size and Prospect (2021-2032)
    • 1.7.5 Asia-Pacific Targeted Metabolomics Market Size and Prospect (2021-2032)
    • 1.7.6 South America Targeted Metabolomics Market Size and Prospect (2021-2032)
    • 1.7.7 Middle East & Africa Targeted Metabolomics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Creative Proteomics
    • 2.1.1 Creative Proteomics Details
    • 2.1.2 Creative Proteomics Major Business
    • 2.1.3 Creative Proteomics Targeted Metabolomics Product and Solutions
    • 2.1.4 Creative Proteomics Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Creative Proteomics Recent Developments and Future Plans
  • 2.2 Metabolon
    • 2.2.1 Metabolon Details
    • 2.2.2 Metabolon Major Business
    • 2.2.3 Metabolon Targeted Metabolomics Product and Solutions
    • 2.2.4 Metabolon Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Metabolon Recent Developments and Future Plans
  • 2.3 Allumiqs
    • 2.3.1 Allumiqs Details
    • 2.3.2 Allumiqs Major Business
    • 2.3.3 Allumiqs Targeted Metabolomics Product and Solutions
    • 2.3.4 Allumiqs Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Allumiqs Recent Developments and Future Plans
  • 2.4 CD Genomics
    • 2.4.1 CD Genomics Details
    • 2.4.2 CD Genomics Major Business
    • 2.4.3 CD Genomics Targeted Metabolomics Product and Solutions
    • 2.4.4 CD Genomics Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 CD Genomics Recent Developments and Future Plans
  • 2.5 Alfa Chemistry
    • 2.5.1 Alfa Chemistry Details
    • 2.5.2 Alfa Chemistry Major Business
    • 2.5.3 Alfa Chemistry Targeted Metabolomics Product and Solutions
    • 2.5.4 Alfa Chemistry Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Alfa Chemistry Recent Developments and Future Plans
  • 2.6 Novelgene Technologies
    • 2.6.1 Novelgene Technologies Details
    • 2.6.2 Novelgene Technologies Major Business
    • 2.6.3 Novelgene Technologies Targeted Metabolomics Product and Solutions
    • 2.6.4 Novelgene Technologies Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Novelgene Technologies Recent Developments and Future Plans
  • 2.7 Biognosys
    • 2.7.1 Biognosys Details
    • 2.7.2 Biognosys Major Business
    • 2.7.3 Biognosys Targeted Metabolomics Product and Solutions
    • 2.7.4 Biognosys Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Biognosys Recent Developments and Future Plans
  • 2.8 Arome Science
    • 2.8.1 Arome Science Details
    • 2.8.2 Arome Science Major Business
    • 2.8.3 Arome Science Targeted Metabolomics Product and Solutions
    • 2.8.4 Arome Science Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Arome Science Recent Developments and Future Plans
  • 2.9 Dalton Bioanalytics
    • 2.9.1 Dalton Bioanalytics Details
    • 2.9.2 Dalton Bioanalytics Major Business
    • 2.9.3 Dalton Bioanalytics Targeted Metabolomics Product and Solutions
    • 2.9.4 Dalton Bioanalytics Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Dalton Bioanalytics Recent Developments and Future Plans
  • 2.10 Panome Bio
    • 2.10.1 Panome Bio Details
    • 2.10.2 Panome Bio Major Business
    • 2.10.3 Panome Bio Targeted Metabolomics Product and Solutions
    • 2.10.4 Panome Bio Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Panome Bio Recent Developments and Future Plans
  • 2.11 BGI
    • 2.11.1 BGI Details
    • 2.11.2 BGI Major Business
    • 2.11.3 BGI Targeted Metabolomics Product and Solutions
    • 2.11.4 BGI Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 BGI Recent Developments and Future Plans
  • 2.12 Metware
    • 2.12.1 Metware Details
    • 2.12.2 Metware Major Business
    • 2.12.3 Metware Targeted Metabolomics Product and Solutions
    • 2.12.4 Metware Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Metware Recent Developments and Future Plans
  • 2.13 Applied Protein Technology
    • 2.13.1 Applied Protein Technology Details
    • 2.13.2 Applied Protein Technology Major Business
    • 2.13.3 Applied Protein Technology Targeted Metabolomics Product and Solutions
    • 2.13.4 Applied Protein Technology Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Applied Protein Technology Recent Developments and Future Plans
  • 2.14 Shanghai Obio Technology
    • 2.14.1 Shanghai Obio Technology Details
    • 2.14.2 Shanghai Obio Technology Major Business
    • 2.14.3 Shanghai Obio Technology Targeted Metabolomics Product and Solutions
    • 2.14.4 Shanghai Obio Technology Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Shanghai Obio Technology Recent Developments and Future Plans
  • 2.15 Beijing Biotech Pack Scientific
    • 2.15.1 Beijing Biotech Pack Scientific Details
    • 2.15.2 Beijing Biotech Pack Scientific Major Business
    • 2.15.3 Beijing Biotech Pack Scientific Targeted Metabolomics Product and Solutions
    • 2.15.4 Beijing Biotech Pack Scientific Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Beijing Biotech Pack Scientific Recent Developments and Future Plans
  • 2.16 Abace Biotechnology
    • 2.16.1 Abace Biotechnology Details
    • 2.16.2 Abace Biotechnology Major Business
    • 2.16.3 Abace Biotechnology Targeted Metabolomics Product and Solutions
    • 2.16.4 Abace Biotechnology Targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Abace Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Targeted Metabolomics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Targeted Metabolomics by Company Revenue
    • 3.2.2 Top 3 Targeted Metabolomics Players Market Share in 2025
    • 3.2.3 Top 6 Targeted Metabolomics Players Market Share in 2025
  • 3.3 Targeted Metabolomics Market: Overall Company Footprint Analysis
    • 3.3.1 Targeted Metabolomics Market: Region Footprint
    • 3.3.2 Targeted Metabolomics Market: Company Product Type Footprint
    • 3.3.3 Targeted Metabolomics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Method

  • 4.1 Global Targeted Metabolomics Consumption Value and Market Share by Method (2021-2026)
  • 4.2 Global Targeted Metabolomics Market Forecast by Method (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Targeted Metabolomics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Targeted Metabolomics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Targeted Metabolomics Consumption Value by Method (2021-2032)
  • 6.2 North America Targeted Metabolomics Market Size by Application (2021-2032)
  • 6.3 North America Targeted Metabolomics Market Size by Country
    • 6.3.1 North America Targeted Metabolomics Consumption Value by Country (2021-2032)
    • 6.3.2 United States Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Targeted Metabolomics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Targeted Metabolomics Consumption Value by Method (2021-2032)
  • 7.2 Europe Targeted Metabolomics Consumption Value by Application (2021-2032)
  • 7.3 Europe Targeted Metabolomics Market Size by Country
    • 7.3.1 Europe Targeted Metabolomics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 7.3.3 France Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Targeted Metabolomics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Targeted Metabolomics Consumption Value by Method (2021-2032)
  • 8.2 Asia-Pacific Targeted Metabolomics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Targeted Metabolomics Market Size by Region
    • 8.3.1 Asia-Pacific Targeted Metabolomics Consumption Value by Region (2021-2032)
    • 8.3.2 China Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 8.3.5 India Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Targeted Metabolomics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Targeted Metabolomics Consumption Value by Method (2021-2032)
  • 9.2 South America Targeted Metabolomics Consumption Value by Application (2021-2032)
  • 9.3 South America Targeted Metabolomics Market Size by Country
    • 9.3.1 South America Targeted Metabolomics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Targeted Metabolomics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Targeted Metabolomics Consumption Value by Method (2021-2032)
  • 10.2 Middle East & Africa Targeted Metabolomics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Targeted Metabolomics Market Size by Country
    • 10.3.1 Middle East & Africa Targeted Metabolomics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Targeted Metabolomics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Targeted Metabolomics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Targeted Metabolomics Market Drivers
  • 11.2 Targeted Metabolomics Market Restraints
  • 11.3 Targeted Metabolomics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Targeted Metabolomics Industry Chain
  • 12.2 Targeted Metabolomics Upstream Analysis
  • 12.3 Targeted Metabolomics Midstream Analysis
  • 12.4 Targeted Metabolomics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Targeted Metabolomics market size was valued at US$ 120 million in 2025 and is forecast to a readjusted size of US$ 253 million by 2032 with a CAGR of 11.3% during review period.
    Targeted metabolomics is a study in which defined metabolites in a sample are identified and quantitatively analyzed. Quantitation and semi-quantitation of defined metabolites are undertaken through the use of internal standard compounds. Targeted metabolomics has an advantage of high specificity and accuracy. Thus, this method has been widely used to analyze and compare multiple targeted metabolites under different physiological states, and is a critical analytical method for discovery of new biomarker in metabolic diseases and study of early diagnosis of diseases.
    Targeted metabolomics is a rapidly growing and highly commercialized sub-segment of the metabolomics market. Its strong growth is primarily due to its superior suitability for absolute quantification, batch-to-batch standardization, clinical translation, and biomarker validation compared to non-targeted metabolomics. Demand is mainly driven by drug development, clinical research, precision medicine, nutrition, and chronic disease management. The core technologies are LC-MS/MS, particularly triple quadrupole platforms, with business models focusing on standardized panels, customized panels, and outsourced testing services. In terms of competition, upstream instrument manufacturers such as SCIEX, Thermo Fisher, Agilent, Waters, and Bruker dominate, while biocrates is a representative player in standardized reagent kits/solutions. Service providers include Metabolon, Creative Proteomics, Novogene, BGI, and Metware. Overall, targeted metabolomics represents a sub-segment with high technological barriers, strong service attributes, and a clear focus on clinical and industrial applications.
    This report is a detailed and comprehensive analysis for global Targeted Metabolomics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Method and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Targeted Metabolomics market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Targeted Metabolomics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Targeted Metabolomics market size and forecasts, by Method and by Application, in consumption value ($ Million), 2021-2032
    Global Targeted Metabolomics market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Targeted Metabolomics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Targeted Metabolomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Proteomics, Metabolon, Allumiqs, CD Genomics, Alfa Chemistry, Novelgene Technologies, Biognosys, Arome Science, Dalton Bioanalytics, Panome Bio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Targeted Metabolomics market is split by Method and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Method and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Method
    NMR
    GC-MS
    LC-MS
    HPLC-MS
    Market segment by Service Type
    Standardized Quantitative Services
    Customized Service
    Market segment by Application
    Academic and Research Institutions
    Pharmaceutical and Biotechnology Companies
    Contract Research Organizations
    Market segment by players, this report covers
    Creative Proteomics
    Metabolon
    Allumiqs
    CD Genomics
    Alfa Chemistry
    Novelgene Technologies
    Biognosys
    Arome Science
    Dalton Bioanalytics
    Panome Bio
    BGI
    Metware
    Applied Protein Technology
    Shanghai Obio Technology
    Beijing Biotech Pack Scientific
    Abace Biotechnology
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Targeted Metabolomics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Targeted Metabolomics, with revenue, gross margin, and global market share of Targeted Metabolomics from 2021 to 2026.
    Chapter 3, the Targeted Metabolomics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Method and by Application, with consumption value and growth rate by Method, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Targeted Metabolomics market forecast, by regions, by Method and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Metabolomics.
    Chapter 13, to describe Targeted Metabolomics research findings and conclusion.

    Buy now